PHASE Scientific Americas

09/02/2026

The respiratory season is approaching, bringing higher patient volumes and greater pressure to make confident treatment decisions at the point of care.

Join PHASE Scientific Americas at MTMC Showcase – on September 10 at White Pines Golf Course in Bensenville, IL, to learn how distribution partners can support customers through respiratory season with FebriDx®.

FebriDx is a rapid point-of-care test that helps differentiate bacterial from non-bacterial acute respiratory infections after 10 minutes, supporting more informed treatment decisions and antibiotic stewardship.

Attending MTMC Showcase – Chicagoland? Connect with Colleen to discuss , respiratory-season opportunities and resources to support your customers.

We look forward to seeing you in .

09/01/2026

Antimicrobial resistance doesn’t stay put. It moves across borders through people, animals, food and goods, and travel increases the chances for resistant bacteria and fungi to spread.

Smart habits help lower that risk. Wash your hands, stay current on recommended vaccines and handle food safely. These simple steps protect you and the people you’re traveling with.

Three smart travel tips to keep AMR risk low:

Pack a small care kit so you can handle minor issues on your own — the CDC’s Travel Health Kit offers helpful guidance on what to include.

Save reputable clinic info before you go.

Use safe water sources to lower infection risk.

Travel smart and support AMR prevention wherever you go.

CDC Travel Health Kit: https://www.cdc.gov/yellow-book/hcp/preparing-international-travelers/travel-health-kits.html

Want more AMR insights and practical prevention tips? Sign up for our newsletter: https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7487582603651387392

08/31/2026

Today is International Overdose Awareness Day.

Safer communities start with awareness, access and the right tools.

Today, we recognize the individuals, families and communities affected by overdose and the organizations working every day to reduce harm and save lives.

The INDICAID® Xylazine Rapid Detection Test and INDICAID Fentanyl Rapid Detection Test are designed to support harm reduction programs with simple workflows, built-in controls and rapid, reliable results — helping teams make informed decisions when time matters.

One minute. Actionable information. Real-world impact.

For product information or ordering, contact [email protected].

Resources: https://www.overdoseday.com/

08/21/2026

08/20/2026

Respiratory season is approaching, putting pressure on clinics to manage higher patient volume and make timely care decisions. This creates a near-term opportunity for distribution partners to support customer conversations around faster respiratory assessment at the point of care.

The PHASE team will attend the MTMC Showcase in Richmond, Virginia, on August 27 to support distribution partners ahead of peak seasonal demand. The team will highlight FebriDx®, a rapid point-of-care test that helps differentiate bacterial from non-bacterial acute respiratory infections after 10 minutes, supporting more informed treatment decisions and antibiotic stewardship efforts.

If you are attending, connect with Rebecca and Jessica to discuss how FebriDx® can support respiratory-season account planning and help identify customers where expanded diagnostic testing may be a fit.

We look forward to connecting in Richmond.

08/18/2026

Antimicrobial resistance (AMR) is a growing challenge that affects human, animal and environmental health.

AMR develops when microorganisms no longer respond to the medicines designed to treat them. Misuse and overuse of antibiotics in healthcare, agriculture and communities contribute to this process, making some infections harder to manage.

Addressing AMR requires steady, coordinated action: responsible antibiotic use, strong infection prevention, better surveillance, ongoing research and a One Health approach that connects human, animal and environmental health.

By using antibiotics wisely today, we help preserve their effectiveness for the future.

Interested in how rapid, point‑of‑care diagnostics support stewardship? Explore FebriDx®: https://phasescientificamericas.com/products-and-services/indicaid-poc/febridx

08/13/2026

Meet Team Basil.

The first team to stir up excitement, and the first to show… something. Movement? Momentum? Mysterious soil activity? Hard to say, but Basil is definitely up to something, and the whole office is rooting for them (pun very much intended).

These seeds have a reputation for getting started early, which has turned several employees into full‑time pot‑checkers with part‑time job titles. People are hovering. People are narrating. People are bringing their lunch over just to “check in”. One person may or may not have already given theirs a name.

Whatever’s happening in those pots, Team Basil is convinced it’s progress.

Scientific rigor, this is not.
Unshakable confidence, absolutely.
And honestly? We support the delusion.

Front row seats are free.

08/11/2026

Summer cold that just won’t quit? Antibiotics are not needed for colds or flu, and taking antibiotics when they’re not required can cause side effects and push antibiotic resistance forward.

When symptoms linger, frontline providers need fast clarity to support treatment decisions. FebriDx® is a rapid, self‑contained test that differentiates bacterial acute respiratory infections from non‑bacterial etiology and delivers results after 10 minutes, helping clinicians make confident, on‑the‑spot decisions in CLIA‑waived settings. FebriDx reliably rules out a bacterial infection with a 99% negative predictive value.

What you can do:

Talk with your healthcare provider about the best treatment for your symptoms

Ask how to feel better if antibiotics aren’t needed

Only take antibiotics exactly as prescribed

Ask your clinic if they use FebriDx to support timely treatment decisions

Learn how PHASE strengthens frontline care: https://phasescientificamericas.com/products-and-services/indicaid-poc/indicaid-febridx-test

08/10/2026

The respiratory season comes fast, and clinics feel it first. Symptoms overlap, patient volume rises and teams need tools that help them move quickly and confidently.

FebriDx® is a rapid, point of care test that differentiates bacterial acute respiratory infections from non‑bacterial etiology and delivers results after 10 minutes, giving clinicians clear information right at the point of care. FebriDx confidently rules out a bacterial infection with a 99% negative predictive value whilst ensuring bacterial infections are not overlooked.

Preparation starts with having the right tools in place. Are you prepared for respiratory season?

Learn how FebriDx supports confident treatment decisions whilst improving workflow: https://phasescientificamericas.com/products-and-services/indicaid-poc/indicaid-febridx-test

08/10/2026

Another successful ADLM is in the books.

Thank you to everyone who connected with PHASE Scientific in Anaheim. We appreciated the opportunity to engage with laboratory leaders, healthcare organizations and distribution partners to discuss the future of diagnostic testing.

The conversations reinforced what we're hearing across the industry: healthcare organizations continue to look for practical, accessible diagnostic solutions that support better clinical decisions, improve workflow efficiency and expand access to care.

We're excited to continue those conversations in the weeks ahead. If we missed you at Association for Diagnostics & Laboratory Medicine Annual Meeting —or you'd like to learn more about PHASE Scientific's diagnostic portfolio—contact us at [email protected].

Thank you again for making ADLM2026 such a valuable event. We look forward to staying connected.